Cargando…
Targeting DNA repair with aphidicolin sensitizes primary chronic lymphocytic leukemia cells to purine analogs
Purine analogs are among the most effective chemotherapeutic drugs for the treatment of chronic lymphocytic leukemia (CLL). However, chemoresistance and toxicity limit their clinical use. Here, we report that the DNA polymerase inhibitor aphidicolin, which displayed negligible cytotoxicity as a sing...
Autores principales: | Starczewska, Eliza, Beyaert, Maxime, Michaux, Lucienne, Vekemans, Marie-Christiane, Saussoy, Pascale, Bol, Vanesa, Echarri, Ainhoa Arana, Smal, Caroline, Van Den Neste, Eric, Bontemps, Françoise |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122396/ https://www.ncbi.nlm.nih.gov/pubmed/27223263 http://dx.doi.org/10.18632/oncotarget.9525 |
Ejemplares similares
-
Reevaluation of ATR signaling in primary resting chronic lymphocytic leukemia cells: evidence for pro-survival or pro-apoptotic function
por: Beyaert, Maxime, et al.
Publicado: (2017) -
Structural basis for inhibition of DNA replication by aphidicolin
por: Baranovskiy, Andrey G., et al.
Publicado: (2014) -
Isolation and Characterization of Aphidicolin Derivatives from Tolypocladium inflatum
por: Lin, Jie, et al.
Publicado: (2017) -
Selective Killing of Transformed Fibroblasts by Combined Treatment with Cycloheximide and Aphidicolin
por: Okuda, Atsuyuki, et al.
Publicado: (1989) -
Live analysis of free centrosomes in normal and aphidicolin-treated Drosophila embryos
Publicado: (1996)